Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
11 Cards in this Set
- Front
- Back
What is deficient in X-linked SCIDS? What still works? Why?
|
- absence of T cells and NK cells
- B cells present but do not function well - non functioning gamm c chain |
|
What is deficient in Autosomal recessive SCIDS? What still works?
|
- Absence of B and T cells
- NK cells still function |
|
What is one of the most common types of autosomal recessive SCIDS?
|
- Adenosine deaminase deficiency
|
|
What is the role of adenosine deaminase?
|
- enzyme of purine salvage pathway
- gives primary source of nucleotides |
|
What happens when adenosine deaminase is deficient?
|
- increase in dATP and ATP
- if dATP constitutes more than 1% of total ATP levels, DNA synthesis halts - Highest level of ADA activity is in thymus and lymph tx, so most profoundly affected (cause defective B and T cells) |
|
Discuss Enzyme Replacement therapy in ADA deficiency
|
- Added PEG to ADA which enables modified enzyme to remain in blood for 1-2 weeks and only reduces activity by 40%
- increases amount in circulation - tricks immune so there is no mounted attack against the bovine ADA |
|
Discuss T cell gene therapy
|
- easier to growth than hematopoietic stem cells
- Isolate from patients and culture with IL-2 - Insert ADA gene via retrovirus - select for Neo resistance (selective marker) - amplified - put back into patient - requires repeated treatments every 2-3 months |
|
Discuss hematopoietic stem cell therapy for X-linked SCID
|
- hematopoietic stem cells express CD-34 cells
Methods - harvest 1/2 pint of hematopoietic stem cells - isolate CD34 cells - partially wipe out old marrow (cyto reduction) - inject new marrow - isolate patient - takes weeks to replace and build up |
|
What were problems with hematopoietic stem cell therapy for X-linked SCID?
|
- 25% patients developed leukemia
|
|
Describe the progression of treatments for SCID
|
- heavy antibiotics
- bone marrow transplant - enzyme replacement therapy - gene therapy |
|
Discuss the success of bone marrow transplant for ADA-SCID
|
- HLA identical sibling 90%
- HLA haplo sibiling/relative 65% - HLA identical non-relative 50% |